Point72 Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-81
| Closed | -$5.98K | – | 1918 |
|
|
2023
Q1 | $5.98K | Buy |
+81
| New | +$5.98K | ﹤0.01% | 1536 |
|
|
2022
Q3 | – | Sell |
-4,649
| Closed | -$259K | – | 1219 |
|
|
2022
Q2 | $259K | Sell |
4,649
-132,408
| -97% | -$7.38M | ﹤0.01% | 933 |
|
|
2022
Q1 | $9.62M | Buy |
137,057
+50,335
| +58% | +$3.53M | 0.04% | 478 |
|
|
2021
Q4 | $8.36M | Buy |
+86,722
| New | +$8.36M | 0.03% | 528 |
|
|
2020
Q4 | – | Sell |
-3,637
| Closed | -$216K | – | 982 |
|
|
2020
Q3 | $216K | Buy |
+3,637
| New | +$216K | ﹤0.01% | 804 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 979 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 954 |
|